This opens the possibility of routinely using plasma p-tau to improve the confidence in an AD diagnosis in primary care and administering symptomatic treatment (e.g. acetylcholinesterase inhibitors or memantine). The gene discussed is ACHE; the disease is Alzheimer disease.